The Portable Adherence Protocol for Home Care Continuity.

kuvos turns complex prescriptions and care plans into a clear, timed protocol across smartphone, Smart TV, and smartwatch surfaces — so hospitals, insurers, and care teams can keep an authorised plan alive after the patient goes home.

Human-authorized. Accessibility-led. Built for real homes.

One authorised protocolPhone · Smart TV · Smartwatch
Living roomCURRENT STEP

Morning movement session

4 guided steps · About 8 minutes

Confirm with remote

Large captions · Strong contrast · Audio option

The execution gap

The episode ends at discharge. The plan does not.

A hospital may complete the clinical episode, but the patient still has to execute the plan at home. AHRQ describes discharge as a transfer of information from clinicians to patients and families — medications, warning signs, test results, and follow-up appointments all requiring clear communication and engagement. NCQA's Transitions of Care measure set tracks notification of admission, receipt of discharge information, patient engagement within 30 days, and medication reconciliation after discharge.

The gapThe plan is issued. It is not executed.

The organisation issues the plan, but the patient or supporter must translate it into repeated daily behaviour after leaving the facility.

The riskVisibility is lost, not the plan.

The post-discharge plan loses visibility, comprehension, or follow-through in the home — especially where incapacity affects execution.

How to measure itFall-off, not a borrowed statistic.

Low conversion should be measured as fall-off from discharge instruction to confirmed engagement, completed authorised actions, follow-up connection, or medication reconciliation.

kuvos is positioned as a care-transition execution layer, not a readmission-prevention guarantee. Sources: AHRQ — Care Transitions From Hospital to Home (IDEAL Discharge Planning); NCQA — Transitions of Care; OECD — Integrated care delivery.

Who kuvos is for

A trusted protocol for institutions responsible for continuity of care.

Hospitals, insurers, and healthcare-data buyers use kuvos to extend authorised care plans into the home, support defined high-need populations, and access governed confirmation-event data under explicit permissions. Patients and care circles are the secondary served users whose experience generates the operational value.

The three-surface network

One protocol across the surfaces people already use.

No new dedicated hardware for the core experience. Phone and Smart TV remain the primary clinical surfaces; the smartwatch extends reach without becoming a standalone clinical device.

The three-surface network One authorised protocol reaches the patient on three surfaces: the smartphone and the Smart TV as primary surfaces, and the smartwatch as a companion that extends reach without becoming a standalone clinical device. One authorised protocol Smartphone primary · personal control Smart TV primary · ambient clinical Smartwatch companion surface The three-surface network One authorised protocol reaches the patient on three surfaces: the smartphone and the Smart TV as primary surfaces, and the smartwatch as a companion that extends reach without becoming a standalone clinical device. One authorised protocol Smartphone Smart TV Smartwatch
Accessible by design, not as an afterthought.

kuvos is designed around real mobility and hearing limitations. It does not rely on tiny text, generic beeps, or precise touchscreen gestures as the only path to completion.

Large captionsStrong contrastRemote inputVisual cues Audio optionsHaptic promptsCalmer timing
Trusted-agent controls

AI helps structure the plan. People remain responsible for authorizing it.

kuvos is not an autonomous clinical agent. Its trust layer is built from Locked Draft State, human authorization, source-linked provenance, Care Circle permissions, and tamper-evident confirmation receipts.

The care-plan flywheel Five stages in a loop: a source care plan is ingested, held in a Locked Draft State, authorised by a person, confirmed by the patient as one clear next action, and shared with a permissioned Care Circle, which feeds the next plan. One clear next action for the patient 1 Source care plan authorised plan ingested 2 Locked Draft State held, not yet actionable 3 Human authorization a person approves 4 Patient confirmation one action, confirmed 5 Permissioned Care Circle only what is allowed The care-plan flywheel Five stages in a loop: a source care plan is ingested, held in a Locked Draft State, authorised by a person, confirmed by the patient as one clear next action, and shared with a permissioned Care Circle, which feeds the next plan. One clear next action 1 Source care plan 2 Locked Draft State 3 Human authorization 4 Patient confirmation 5 Permissioned Care Circle
  • AI structures, it does not decide. Fields are extracted with source references, two models are compared, and structured references cross-checked where available.
  • A person authorizes. Nothing actionable reaches the patient before human authorization.
  • Model agreement is not clinical approval. The Locked Draft State is a product and liability boundary.
Review view

Uncertainty is held, not guessed.

The ingestion layer extracts a constrained field set — task or medication name, dose or instruction, timing, frequency, duration — and preserves a link back to the source page or region for every item. Conflicting or uncertain fields are surfaced to the reviewer rather than silently resolved.

Model agreement is not clinical approval. The Locked Draft State is a product and liability boundary: before authorization, the patient sees no actionable protocol.

Draft protocol · under reviewSource: discharge summary, 4 pages
Morning movement session4 guided steps · 09:00 · daily · 6 weeks
p.2 · §3
Wound care checkOnce daily · after morning session · 14 days
p.3 · §1
Analgesia — frequency unclearSource states "as needed" and "twice daily" on different pages Conflict surfaced for reviewer
p.2 / p.4
Locked Draft StateNot visible to the patient Reviewer only
Approved by Dr A. Rahman Authorized 09 Sep, 08:12 Protocol v1.2 Source DS-4417
Confirmation event receiptSigned
Protocol versionv1.2
Event typeStep confirmed
Timestamp09 Sep 2026, 09:14 +08
Device / session signalTV remote · session 8f2c
Consent scopeCare Circle: status only

What this proves: that a configured confirmation event was recorded. It does not claim that a medication was taken, that an instruction was followed perfectly, or that a clinical outcome occurred. The clinical record remains off-chain by default.

Tamper-evident receipts

A record of what actually happened.

When a patient confirms a configured care action on a TV remote, smartphone, or smartwatch, kuvos can record a signed event receipt carrying minimum necessary metadata: protocol version, event type, timestamp, device or session signal, and consent scope.

No PHI in the receiptNo medication namesNo care-plan textWithdrawable consent
Fast path

A faster path through a complex day.

StepOn screenWhat it means

Open. Act. Done.

The served-user experience

Peace of mind without turning care into surveillance.

The Care Circle gives patients and authorized administrators control over who receives updates. A relative living abroad can see that the day is progressing without access to every clinical detail. If a protocol status needs attention, kuvos follows a configured notification path rather than alerting everyone immediately.

A AlexAuthorized Care Circle · abroad Connected
CompletionMaya completed her morning protocol.

No action is needed from you.

Status check-inMaya's 9:00 AM protocol step is still open.

Check in?

EscalationA configured care exception needs attention.

Following the approved escalation path.

The right people see the right amount.

4of 5
checked today
3-day rhythm
MON
TUE
WED
TODAY
FRI
Instead of "lost streak" Your rhythm paused. Continue with the next step.
Governed evidence and buyer value

Make authorised care-plan execution observable between encounters.

For hospitals, the entry point is keeping the discharge plan alive at home. For insurers and risk-bearing groups, it is making authorised care-plan execution observable between encounters. kuvos's claims remain bounded: it can improve visibility, accessibility, and workflow continuity. Only a properly designed pilot can establish effects on readmissions, utilization, cost, or clinical outcomes.

Risk-bearing concernkuvos responseEvidence to validate

Institutional pilot metrics

What we have to prove

Proof questions, held as questions until pilot data exists. Mockups are not presented as clinical outcomes.

Why this matters now

Care is moving home. Execution has not caught up.

kuvos is designed for a global care-at-home reality: more older people, more people living with significant disability, more family support across distance, and more need for accessible digital coordination.

20300people aged 60+ (billions), WHO projection
+50%2030 → 2050
20500people aged 60+ (billions), WHO projection
1.3 billion people — 16% of the global population experience significant disability (WHO).
By 2050, 80% of older people are projected to live in low- and middle-income countries (WHO).

kuvos is for people of any age who need an adherence loop because temporary, permanent, cognitive, sensory, physical, or situational incapacity makes a care plan difficult to execute alone. Ageing is one important cohort within this broader need. These figures provide demographic and care-relevance context only. They are not a claim that every person represented is a kuvos customer or that kuvos has achieved a clinical outcome. Sources: WHO — Ageing and health; WHO — Disability and health.

Safety and trust architecture

A care-plan execution and coordination layer. Not an autonomous prescriber.

Traceable

Every actionable item links to source content and version history.

Reviewable

Conflicts are shown for review rather than silently guessed.

Authorized

Nothing reaches the patient as an actionable protocol before approval.

Permissioned

Care Circle receives only configured information — minimum necessary disclosure.

Resilient

Connectivity loss does not create unreviewed new instructions.

kuvos does not diagnose, prescribe, replace a clinician, or provide emergency care. AI organizes source material; an authorized human controls what becomes active. Any research or analytics use requires explicit authorization, purpose limitation, data minimization, governance review, and withdrawal mechanisms. kuvos does not sell identifiable patient data, and payment activity never activates or changes a clinical instruction.

Founder–market fit

Built from the clinical reality of the people it serves.

kuvos combines clinical experience, lived accessibility insight, healthcare product-building, AI systems, and growth execution. The founding perspective is grounded in the real friction of mobility, hearing, cognition, family distance, and complex daily routines.

Clinical understanding · Lived accessibility · Product discipline

Clinical co-founder · 10 years in practice
Lived patient and accessibility experience
Cross-border startup execution across SEA
Healthcare product, AI systems and growth
FAQ

Questions buyers and families actually ask.

Run a focused pilot

Make the next step clear.

Talk to us about a defined hospital, insurer, or care-programme pilot — one cohort, one operational owner, one measurable workflow outcome, one renewal decision.

To get access to the beta, email us at vipasana@kuvosai.com.

kuvos — Cross-Screen Adherence for the patients ordinary apps leave behind.